Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,309
Closed -$718K 526
2024
Q3
$718K Sell
15,309
-4,780
-24% -$218K 0.23% 181
2024
Q2
$849K Buy
20,089
+6,509
+48% +$285K 0.63% 29
2024
Q1
$600K Sell
13,580
-10,132
-43% -$462K 0.54% 36
2023
Q4
$1.09M Sell
23,712
-7,464
-24% -$317K 0.31% 100
2023
Q3
$1.34M Buy
31,176
+5,643
+22% +$263K 0.4% 54
2023
Q2
$1.22M Buy
25,533
+10,706
+72% +$516K 0.64% 20
2023
Q1
$722K Buy
+14,827
New +$754K 0.43% 54

Other funds holding QGEN

Oak Thistle LLC's QGEN Position: Q4 2024 in Review

Oak Thistle LLC sold out of Qiagen (QGEN) in Q4 2024, closing a stake of 15,309 shares — an estimated $718K sold.

Oak Thistle LLC first reported a position in QGEN in Q1 2023 and held it in 7 quarters. The position peaked at $1.34M in Q3 2023. 324 funds tracked by Wall St. Rank hold QGEN as of Q4 2024.

  • Oak Thistle LLC reported no remaining Qiagen position as of Q4 2024 after selling out during the quarter.
  • Oak Thistle LLC sold 15,309 Qiagen shares in Q4 2024, an estimated $718K.
  • Oak Thistle LLC first reported a position in Qiagen in Q1 2023 and held it in 7 quarters.
  • Oak Thistle LLC's Qiagen position peaked at $1.34M in Q3 2023.
  • 324 funds tracked by Wall St. Rank held Qiagen as of Q4 2024.

Based on Oak Thistle LLC's 13F filing for Q4 2024, filed 14 Jan 2025.